Steven T. Proulx University of Bern; Li Xin Theodor Kocher Institute, Univeristy of Bern; Posted: 12 Jun 2025 It has long been acknowledged that CSF drains to the deep cervical lymph nodes (Bradbury ...

Others praised the study. “This is a very important paper and, in my view, constitutes a real advance in our understanding of how the ApoE alleles/isoforms so profoundly alter one’s risk for ...

On September 26, 2024, the National Institute on Aging (NIA) announced that Masliah had been removed from his position as scientific director of the institute’s neuroscience division after a ...

“It was surprising to see C1q have such a profound effect on neuronal function,” Scott-Hewitt told Alzforum. She believes C1q may regulate translation in neurons of younger mice, but with age, these ...

22 Mar 2024. Old drugs die hard. Despite a string of negative Phase 3 trials, HMTM, a derivative of the malaria drug methylene blue, resurfaced again at AD/PD 2024, held March 5-9 in Lisbon, ...

Not so long ago, a blood test for Alzheimer’s disease seemed a pipe dream. Now, after years of study, the field is awash with sensitive assays that signal the proteopathic culprits Aβ and tau ...

28 Nov 2023. The latest effort to rewrite the diagnostic criteria for Alzheimer’s disease has stirred more than a little controversy. While the proposed revisions have garnered praise from researchers ...

Dennis Selkoe Co-Director, Brigham and Women's Hospital's Ann Romney Center for Neurologic Diseases; Posted: 31 Aug 2023 I am against offering a direct-to-consumer Aβ42/40 blood test for individuals ...

Berislav Zlokovic University of Southern California; Ruslan Rust University of Southern California; Posted: 25 Jul 2023 In recent years, several studies have been conducted to investigate the changes ...

View all comments by Roberta Diaz Brinton; Make a Comment. To make a comment you must login or register.. References News Citations. Does Second X Chromosome Boost Women’s Resilience Against Alzheimer ...

04 May 2023. Score another one for amyloid immunotherapy. The anti-pyroglutamated amyloid antibody donanemab has posted positive top-line results in the Phase 3 Trailblazer-Alz2 study, according to an ...